Chemical injury is one of the most clinically important mechanisms of cellular damage because many are preventable or treatable when recognized early. From acetaminophen overdose to carbon monoxide poisoning, understanding the mechanism of toxicity directly informs the antidote and intervention strategy.
Acetaminophen Hepatotoxicity: The Prototype
Acetaminophen (APAP) is the leading cause of acute liver failure in the United States and United Kingdom. At therapeutic doses: ~95% metabolized by glucuronidation and sulfation (non-toxic); ~5% by CYP2E1 → NAPQI (N-acetyl-p-benzoquinone imine, a reactive toxic metabolite) → immediately neutralized by glutathione.
At overdose doses (>7.5–10 g in adults): Glucuronidation/sulfation pathways become saturated → disproportionately more NAPQI is generated → glutathione stores depleted → NAPQI binds covalently to hepatocyte proteins → centrilobular (zone 3) hepatic necrosis.
Why centrilobular? Zone 3 hepatocytes (near the central vein) are richest in CYP2E1, most hypoxic, and have lowest glutathione reserves — making them most vulnerable.
Antidote: N-acetylcysteine (NAC) — replenishes glutathione; most effective within 8 hours but benefits up to 24h+ post-ingestion. The Rumack-Matthew nomogram guides treatment decisions based on serum APAP level and time since ingestion.
Heavy Metal Toxicity
Lead (Pb): Binds SH (thiol) groups on enzymes → inhibits heme synthesis (→ microcytic anemia, basophilic stippling), disrupts neurodevelopment (children most vulnerable — encephalopathy, cognitive impairment), inhibits δ-aminolevulinic acid dehydratase and ferrochelatase. Sources: old paint, contaminated water pipes. Treatment: chelation with DMSA (succimer) or EDTA.
Mercury (Hg): Organic mercury (methylmercury — fish/seafood) accumulates in CNS → paresthesias, ataxia, visual/hearing loss; inorganic mercury → renal tubular injury. Binds selenocysteine residues, disrupting antioxidant enzymes.
Arsenic (As): Uncouples mitochondrial oxidative phosphorylation; causes peripheral neuropathy, skin changes (Mees' lines on nails, hyperpigmentation), and increases cancer risk (skin, lung, bladder).
Carbon tetrachloride (CCl4): Classic experimental hepatotoxin. CYP2E1 converts CCl4 → CCl3• (trichloromethyl radical) → lipid peroxidation → hepatocyte membrane destruction → centrilobular necrosis. Historical use as dry-cleaning solvent (now largely banned).
Nephrotoxic Cellular Injury
Aminoglycosides (gentamicin, tobramycin, amikacin): Filtered by glomerulus → accumulate in proximal tubule lysosomes → mitochondrial dysfunction → proximal tubular cell necrosis → acute tubular necrosis (ATN). Risk factors: pre-existing renal disease, volume depletion, prolonged therapy, advanced age. Prevention: single daily dosing (reduces peak-dependent toxicity), monitor trough levels, adequate hydration.
Contrast-induced nephropathy (CIN):Direct tubular toxicity from osmotic/chemical injury + renal medullary vasoconstriction → tubular ischemia. Risk factors: pre-existing CKD (eGFR <60), diabetes, dehydration, high contrast volume. Prevention: IV hydration pre- and post-procedure, hold nephrotoxic drugs, consider iso-osmolar contrast.
NSAIDs: Block prostaglandin synthesis → renal afferent arteriole constriction → reduced GFR. Particularly dangerous in states of reduced effective circulating volume (heart failure, cirrhosis, dehydration) where prostaglandins are critical to maintain renal perfusion.
Carbon Monoxide Poisoning: The Silent Killer
CO is colorless, odorless, and tasteless — the "silent killer." Sources: gas heaters, generators, car exhaust in enclosed spaces, house fires.
Mechanism: CO binds hemoglobin with 200–250× greater affinity than O2, forming carboxyhemoglobin (COHb) → reduced O2-carrying capacity. CO also shifts the oxyhemoglobin dissociation curve leftward (remaining Hgb holds O2 more tightly, less delivery to tissues). CO directly inhibits cytochrome c oxidase (Complex IV of the mitochondrial ETC) → cellular respiration fails even in cells that receive some O2.
The SpO2 trap: Standard pulse oximetry cannot differentiate oxyhemoglobin from carboxyhemoglobin — SpO2 reads falsely normal/high. A patient with 40% COHb may show SpO2 of 99%. Accurate measurement requires co-oximetry (arterial blood gas with multi-wavelength analysis). Symptoms: headache, nausea, confusion, "cherry red" skin (late sign, unreliable).
Treatment:100% O2 via non-rebreather mask (reduces COHb half-life from ~5h on room air to ~90 min); hyperbaric O2 (HBO, 2.5–3 ATA) reduces half-life to ~20–30 min and is indicated for: LOC, neurological deficits, cardiac involvement, COHb >25%, pregnancy, pediatric patients.